Appreciate the skepticism, but I’d rather decode timing and structural moves than speculate on motives. Advent’s acquisition, Roswell’s licensing, and MHRA clock activation suggest consolidation ahead of a strategic pivot—not retreat. Let’s see what unfolds.
The more I read your posts, the more bat-snit-crazy they seem.